Notice of Preliminary Results

Neuropharm Group plc (AIM: NPH), a specialty pharmaceutical company focused on neurodevelopmental disorders, will announce its preliminary results for the year ended 30 June 2009 on Wednesday 30 September 2009.

For further information please contact:

Neuropharm +44 (0) 1372 371 171

Robert Mansfield, Chief Executive Officer

Graham Yeatman, Chief Financial Officer

Piper Jaffray Ltd. +44 (0) 20 3142 8700

Neil Mackison, Rupert Winckler

Buchanan Communications +44 (0) 20 7466 5000

Mark Court, Mary-Jane Elliot, Catherine Breen

Notes to Editors:

About Neuropharm

Neuropharm is a speciality pharmaceutical company focused on the development of medicines for the treatment and management of neurodevelopmental disorders. Please visit www.neuropharm.co.uk for further information.